
LIST OF PUBLICATIONS:

1.	Pavani A, Naushad SM, Lakshmitha G, Nivetha S, Stanley BA, Malempati AR, Kutala VK. Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirement. Pharmacogenomics. 2016 Aug; 17(12):1315-25.
2.	Addepalli Pavani, Shaik Mohammad Naushad, Rajasekar Manoj Kumar, Murali Srinath, Amaresh Rao Malempati, Vijay Kumar Kutala. Artificial neural network-based pharmacogenomic algorithm for warfarin dose optimization. Pharmacogenomics. 2016; 17(2):121-131.
3.	Pavani, V.K. Kutala, A.R. Malempati, S.M. Naushad. Pharmacogenomic and Pharmacokinetic Models of Warfarin and Its Application in Personalized Medicine. Public Health Genomics.  2015; 18 (1):1–51. 
4.	Addepalli Pavani, Shaik Mohammad Naushad, Alex Stanley B, Renganathan Gnanambal Kamakshi, Krishnan Abinaya, Vijay Kumar Kutala. Mechanistic insights into the effect of CYP2C9*2 and CYP2C9*3 variants on the 7-hydroxylation of warfarin. Pharmacogenomics. 2015; 16(4):393-400.
5.	Addepalli Pavani, Shaik Mohammad Naushad, Vijay Kumar Kutala. Methodological issues in the development of Pharmacogenomic algorithms: Warfarin Pharmacogenomics as an example. Pharmacogenomics. 2014 Jun; 15 (8):1125-32.
6.	Pavani A, Naushad SM, Rupasree Y, Kumar TR, Malempati AR, Pinjala RK, Mishra RC, Kutala VK. Retrospective evidence for clinical validity of expanded genetic model in warfarin dose optimization in South Indian population. Pharmacogenomics. 2012 Jun; 13(8):869-878.
7.	Pavani A, Naushad SM, Rupasree Y, Kumar TR, Malempati AR, Pinjala RK, Mishra RC, Kutala VK. Optimization of warfarin dose by population-specific pharmacogenomic algorithm. Pharmacogenomics J. 2012 Aug; 12(4):306-11.
8.	Pavani Addepalli, Naushad Shaik Mohammad, Ramesh Kumar T, Amaresh Rao M, Ramakrishna Pinjala, and Kutala VK. Development of Pharmacogenomic Algorithm for Warfarin Dose Monitoring in Indian Patients. Circulation. 23 Nov 2010; 122: A13967.
9.	Naushad SM, Shree Divyya, Pavani A, Rupasree Y, Raghunadha Rao D, Suryanarayana Raju G, Vijay Kumar Kutala. Clinical Utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction. J Med Allied Sci. January 2011; 1 (1):7-14. 
10.	Mohammad NS, Yedluri R, Addepalli P, Gottumukkala SR, Digumarti RR, Kutala VK. Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem. 2011 Mar; 349(1-2):159-67. 
11.	Naushad SM, Pavani A,  Rupasree Y, Sripurna D,  Raju SGN, Raghunadha Rao, D, Vijay K. Kutala. Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer risk. Indian J Biochem Biophys. 2011 Aug; 48(4): 283-289.
12.	Naushad SM, Pavani A, Digumarti RR, Gottumukkala SR, Kutala VK. Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer. Mol Biol Rep. 2011 Nov; 38(8):4893-4901.
13.	Y Rupasree, A Pavani, L Rajasekhar, SM Naushad, VK Kutala.  Impact of aberrations in xenobiotic metabolism on the susceptibility to systemic lupus erythematosus. Indian Journal of Rheumatology. 2011 Nov; 3 (6), S4.
14.	Naushad SM, Reddy CA, Rupasree Y, Pavani A, Digumarti RR, Gottumukkala SR, Kuppusamy P, Kutala VK. Cross-Talk between One-Carbon Metabolism and Xenobiotic Metabolism: Implications on Oxidative DNA Damage and Susceptibility to Breast Cancer. Cell Biochem Biophys. 2011 Dec; 61(3):715-723.
15.	Naushad SM, Pavani A, Rupasree Y, Divyya S, Deepti S, Digumarti RR, Gottumukkala SR, Kutala VK. Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer. Mol Carcinogenesis. 2012 Oct; 51(1):32-41. 
16.	SM Naushad, P Dorababu, Y Rupasree, A Pavani, D Raghunadharao. Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology. 2019 May; 83 (5):875-880.
17.	SM Naushad, A Pavani, Y Rupasree, T Hussain, SA Alrokayan, VK Kutala. Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases. Pharmacological Reports. 2019 Jun; 71 (3):385-392.

SEMINAR, SYMPOSIUM AND WORKSHOP ATTENDED:

Oral:
•	Pavani Addepalli, Naushad Shaik Mohammad, Ramesh Kumar T, Amaresh Rao M, Ramakrishna Pinjala, and Kutala VK. “Development of Pharmacogenomic Algorithm for Warfarin Dose Monitoring in Indian Patients”. American Heart Association (AHA) annual conference, 2010: A13967.
•	Addepalli Pavani, Amaresh Rao Malempati, Y. Prameela Devi, A.Uma, Vijay Kumar Kutala. “Haplotypes of CYP2C9 and VKORC1 as pharmacogenomic determinants of warfarin dose in patients with thrombotic events” in National Conference on Biomarkers for Diseases - Prospects & Challenges, held at Hyderabad during Feb 24- 25, 2012.
•	A. Pavani, Shaik M. Naushad, Amaresh Rao, Ramesh C Mishra, Vijay K Kutala. Oral presentation entitled “Application of pharmacogenomic algorithms in clinical practice” in Indian Academy of Biomedical Sciences (IABS-2012) held at Lucknow 2012.   
•	Addepalli Pavani, Shaik Mohammad Naushad, Balraj Alex Stanley, R G Kamakshi, K Abinaya, M Amaresh Rao, Addepally Uma, Vijay Kumar Kutala. “Pharmacokinetic model of warfarin and its application in personalized medicine” in Indian Academy of Biomedical Sciences (IABS-2015) held at Hyderabad 2015.   

Posters:
•	A. Pavani, Shaik M. Naushad, Amaresh Rao,  Ramesh C Mishra, Vijay K Kutala. “Forecasting the Personalized Warfarin Dose in Indian Patients Using Pharmacogenomic algorithm” in XXXVIth Annual Conference of The Indian Society of Human Genetics (ISHG-2011) held at Manipal University during Feb 14-16, 2011.
•	A. Pavani, Shaik M. Naushad, Amaresh Rao,  Ramesh C Mishra, Vijay K Kutala. A warfarin dosing algorithm using clinical and pharmacogenetic data in South Indian patients undergoing heart valve replacement. National Academy of Medical Sciences (NAMS – 2013) held at Jodhpur during 25-27 October 2013. 
